DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Eli Lilly - 3 IHE - 1 Johnson - 1 JNJ - 1 MRK - 1 Frank Cappelleri - 1 Katie Stockton - 1 Wegovy - 1
Top related locs:
U.S LLY Danish
Top related orgs:
U.S . Pharmaceuticals - 3 IHE - 2 Merck - 1 CNBC - 1 NBC UNIVERSAL - 1 Fairlead - 1 CNBC Pro - 1 Securities - 1

Search resuls for: "IHE"


3 mentions found


☆ Pharma ETF that's gone nowhere for 9 years forming 'monstrous bullish pattern,' according to the charts
  + stars: | 2024-06-26 | by ( Frank Cappelleri | Will Tamplin | Fairlead Strategies | ) www.cnbc.com   time to read: +4 min
The iShares U.S. Pharmaceuticals ETF (IHE) is up 9% since July 2015, when it hit a fresh all-time high. All of the back-and-forth movement since 2015 has produced what could be a monstrous bullish pattern. But we're trying to capture a major breakout from an area that's done next to nothing in nearly a decade. INVA, on the other hand, bottomed in March 2023, and just recently broke out of a large inverse head & shoulders pattern. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.
Persons: IHE, Eli Lilly, Johnson, JNJ, MRK, Frank Cappelleri Organizations: U.S . Pharmaceuticals, IHE, Merck, CNBC, NBC UNIVERSAL Locations: U.S, LLY
☆ Pharma stocks have quietly outperformed. Here’s one way to play the space
  + stars: | 2024-02-20 | by ( Katie Stockton | ) www.cnbc.com   time to read: +6 min
— Katie Stockton with Will Tamplin Access research from Fairlead Strategies for free here . Fairlead Strategies Disclaimer: This communication has been prepared by Fairlead Strategies LLC ("Fairlead Strategies") for informational purposes only. Securities, investment products, other financial products or strategies discussed herein may not be suitable for all investors. The recipient of this information must make its own independent decisions regarding any securities, investment products or other financial products mentioned herein. This material is not to be reproduced or redistributed absent the written consent of Fairlead Strategies.
Persons: Eli Lilly, Katie Stockton Organizations: U.S . Pharmaceuticals, IHE, Fairlead, CNBC Pro, Securities Locations: U.S
☆ This pharma ETF is headed for its best week of the year as investors cheer new weight loss drugs
  + stars: | 2023-08-11 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com   time to read: +1 min
The excitement around new drugs that can help people shed weight quickly has created a banner week for certain health care ETFs. That would be its best stretch since the week ended June 24, 2022, when the fund gained 8.3%, according to FactSet. IHE 5D mountain The iShares fund focused on drugmakers is on track for its best week of the year. Zoetis , the third largest holding in the iShares fund, has rallied more than 6% this week after its second-quarter report. Meanwhile, the VanEck Pharmaceutical ETF (PPH) has gained more than 4% so far this week, which would also be its best week of the year.
Persons: Eli Lilly, Wegovy Organizations: U.S . Pharmaceuticals, Mounjaro, Novo Nordisk, VanEck Pharmaceutical Locations: U.S, Danish
0 next >>
Total: 3